Oregon Public Employees Retirement Fund Sells 509 Shares of PRA Health Sciences Inc (NASDAQ:PRAH)

Oregon Public Employees Retirement Fund lowered its stake in shares of PRA Health Sciences Inc (NASDAQ:PRAH) by 2.1% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 23,836 shares of the medical research company’s stock after selling 509 shares during the period. Oregon Public Employees Retirement Fund’s holdings in PRA Health Sciences were worth $2,649,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Metropolitan Life Insurance Co NY raised its stake in shares of PRA Health Sciences by 4.4% during the 3rd quarter. Metropolitan Life Insurance Co NY now owns 20,582 shares of the medical research company’s stock worth $2,042,000 after purchasing an additional 858 shares in the last quarter. California Public Employees Retirement System raised its stake in PRA Health Sciences by 35.0% in the 3rd quarter. California Public Employees Retirement System now owns 151,093 shares of the medical research company’s stock valued at $14,993,000 after acquiring an additional 39,207 shares during the period. Millennium Management LLC raised its stake in PRA Health Sciences by 66.4% in the 3rd quarter. Millennium Management LLC now owns 760,496 shares of the medical research company’s stock valued at $75,464,000 after acquiring an additional 303,514 shares during the period. Kornitzer Capital Management Inc. KS bought a new stake in PRA Health Sciences in the 3rd quarter valued at $21,317,000. Finally, Eagle Asset Management Inc. raised its stake in PRA Health Sciences by 3.0% in the 3rd quarter. Eagle Asset Management Inc. now owns 737,266 shares of the medical research company’s stock valued at $73,158,000 after acquiring an additional 21,324 shares during the period. Institutional investors own 98.34% of the company’s stock.

Shares of NASDAQ PRAH opened at $111.22 on Friday. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.10 and a quick ratio of 1.10. The stock’s fifty day moving average price is $106.56 and its two-hundred day moving average price is $102.74. PRA Health Sciences Inc has a one year low of $85.00 and a one year high of $115.50. The firm has a market cap of $6.97 billion, a price-to-earnings ratio of 24.64, a P/E/G ratio of 1.47 and a beta of 1.21.

PRAH has been the topic of a number of research analyst reports. Goldman Sachs Group cut PRA Health Sciences from a “buy” rating to a “neutral” rating and dropped their price target for the company from $130.00 to $120.00 in a research note on Friday, January 10th. Citigroup initiated coverage on PRA Health Sciences in a research note on Monday, January 6th. They issued a “neutral” rating and a $120.00 price target on the stock. Wolfe Research upgraded PRA Health Sciences from a “peer perform” rating to an “outperform” rating and set a $123.00 price target on the stock in a research note on Thursday, November 14th. BidaskClub cut PRA Health Sciences from a “buy” rating to a “hold” rating in a research note on Saturday, January 11th. Finally, Zacks Investment Research cut PRA Health Sciences from a “hold” rating to a “sell” rating and set a $116.00 price target on the stock. in a research note on Tuesday, December 31st. One analyst has rated the stock with a sell rating, eight have issued a hold rating and four have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $116.40.

PRA Health Sciences Profile

PRA Health Sciences, Inc, a contract research organization, provides outsourced clinical development and data solution services to the biotechnology and pharmaceutical industries worldwide. The company operates in two segments, Clinical Research and Data Solutions. The Clinical Research segment offers product registration services, including clinical trial management, project management, regulatory affairs, therapeutic expertise, clinical operations, data and programming, safety and risk management, biostatistics and medical writing, quality assurance, and late phase services.

See Also: Which market index is the best?

Want to see what other hedge funds are holding PRAH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PRA Health Sciences Inc (NASDAQ:PRAH).

Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)

Receive News & Ratings for PRA Health Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PRA Health Sciences and related companies with MarketBeat.com's FREE daily email newsletter.